What is the effect of statin therapy on mortality among high-risk and low-risk patients after myocardial infarction?
Gottlieb et al. (1998) reported that beta-blockade was associated with a significant reduction in mortality among high-risk and low-risk patients after myocardial infarction. Their study showed that beta-blockade was associated with a reduction in mortality rates for both high-risk and low-risk patients, with the greatest benefit being seen in high-risk patients. They concluded that beta-blockade should be used in the management of myocardial infarction in both high-risk and low-risk patients.